1. bookVolume 54 (2020): Issue 3 (July 2020)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
access type Open Access

Changes in the transcriptional activity of the entero-insular axis genes in streptozotocin-induced diabetes and after the administration of TNF-α non-selective blockers

Published Online: 27 Aug 2020
Volume & Issue: Volume 54 (2020) - Issue 3 (July 2020)
Page range: 160 - 171
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. The aim of the present study was to investigate the transcriptional activity of the GLP-1R, DPP-4, SGLT-1, INSR, and IGF-1R genes in GALT cells of rats with streptozotocin-induced diabetes in both untreated and treated with pentoxifylline, as a non-specific blocker of TNF-α.

Methods. The expression of GLP-1R, DPP-4, SGLT-1, INSR, and IGF-1R genes in GALT cells of rats was studied by real time quantitative polymerase chain reaction.

Results. It was shown that the development of diabetes was accompanied by the decrease of GLP-1R and an increase of DPP-4 genes expression in rat ileum. The administration of pentoxifyl-line to diabetic animals led to an increase in the transcriptional activity of GLP-1R on the 4th week and decrease in transcriptional activity of DPP-4 on the 2nd and 4th weeks of the experiment. An increase in the normalized expression of SGLT-1 on the 4th week of the experimental diabetes was also noted, while the administration of pentoxifylline to diabetic animals did not lead to significant changes in this index. The transcriptional activity of the INSR and IGF-1R genes was reduced in diabetic rats and the administration of the non-specific TNF-α blocker – pentoxifylline led to a significant increase only for INSR gene in animals on the 4th week of the experimental diabetes.

Conclusions. The expression of incretins, glucose transporters, and pro-inflammatory cytokines (e.g. TNF-α) in immune cells may be used as markers of several autoimmune pathologies progression such as type 1 diabetes due to their effect on the balance of pro- and anti-inflammatory factors.

Keywords

Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 62, 1543–1552, 2013.10.1016/j.metabol.2013.07.001380933223932846Search in Google Scholar

Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146–160, 2015.10.1016/j.cell.2015.02.022440028725815992Search in Google Scholar

Brie D, Sahebkar A, Penson PE, Dinca M, Ursoniu S, Serban MC, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GY, Wong ND, Rysz J, Banach M. Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 34, 2318–2329, 2016.10.1097/HJH.000000000000108627512972Search in Google Scholar

Catoi AF, Parvu A, Mureşan A, Busetto L. Metabolic mechanisms in obesity and type 2 diabetes: Insights from bariatric/metabolic surgery. Obes Facts 8, 350–363, 2015.10.1159/000441259564481326584027Search in Google Scholar

Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O’Sullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, Weber JD, Pearce EJ, Jones RG, Pearce EL. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251, 2013.10.1016/j.cell.2013.05.016380431123746840Search in Google Scholar

Chen YM, Chiang WC, Lin SL, Tsai TJ. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update. J Biomed Sci 24, 84, 2017.10.1186/s12929-017-0390-4568355629132351Search in Google Scholar

Clavel T, Haller D. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13, 1153–1164, 2007.10.1002/ibd.2017417476679Search in Google Scholar

Clavel T, Desmarchelier C, Haller D, Gerard P, Rohn S, Lepage P, Daniel H. Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 5, 544–551, 2014.10.4161/gmic.2933125003516Search in Google Scholar

Dai Y, Dai D, Wang X, Ding Z, Mehta JL. DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther 28, 425–432, 2014.10.1007/s10557-014-6539-425022544Search in Google Scholar

de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. Am J Physiol Endocrinol Metab 310, E61–E72, 2016.10.1152/ajpendo.00362.201526530154Search in Google Scholar

Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696–1705, 2006.10.1016/S0140-6736(06)69705-5Search in Google Scholar

El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA. Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sci 126, 81–68, 2015.10.1016/j.lfs.2015.01.03025721294Search in Google Scholar

Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci 1258, 25–33, 2012.10.1111/j.1749-6632.2012.06538.x338470322731712Search in Google Scholar

Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198, 737–746, 2003.10.1084/jem.20030686219418512939344Search in Google Scholar

Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 172, 4661–4665, 2004.10.4049/jimmunol.172.8.466115067038Search in Google Scholar

Garcia FA, Rebouças JF, Balbino TQ, da Silva TG, de Carvalho-Junior CH, Cerqueira GS, de Castro Brito GA, de Barros Viana GS. Pentoxifylline reduces the inflammatory process in diabetic rats: Relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. J Inflamm (Lond) 12, 33, 2015.10.1186/s12950-015-0080-5441166025922592Search in Google Scholar

Gorboulev V, Schurmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187–196, 2012.10.2337/db11-1029323764722124465Search in Google Scholar

Greiner TU, Backhed F. Microbial regulation of GLP-1 and L-cell biology. Mol Metab 5, 753–758, 2016.10.1016/j.molmet.2016.05.012500411727617198Search in Google Scholar

Guzyk MM, Dyakun KO, Yanytska LV, Pryvrotska IB, Krynytska IY, Pishel IM, Kuchmerovska TM. Inhibitors of poly(ADP-Ribose) polymerase-1 as agents providing correction of brain dysfunctions induced by experimental diabetes. Neurophysiology 49, 183–193, 2017.10.1007/s11062-017-9672-4Search in Google Scholar

Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ. Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 149, 1338–1349, 2008.10.1210/en.2007-1137227536718063685Search in Google Scholar

Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW, Kim SH, Cho YW, Park SW, Kim SK, Kim CS, Kim KW, Lee KW. Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study. Diabetol Metab Syndr 7, 64, 2015.10.1186/s13098-015-0060-1Search in Google Scholar

Hogan AE, Tobin AM, Ahern T, Corrigan MA, Gaoatswe G, Jackson R, O’Reilly V, Lynch L, Doherty DG, Moynagh PN, Kirby B, O’Connell J, O’Shea D. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia 54, 2745–2754, 2011.10.1007/s00125-011-2232-3Search in Google Scholar

Hosseini F, Mohammadbeigi A, Aghaali M, Borujerdi R, Parham M. Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial. J Res Med Sci 24, 89, 2019.10.4103/jrms.JRMS_115_18Search in Google Scholar

Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol 9, 37–49, 2016.10.1177/1756283X15616576Search in Google Scholar

Klemann C, Wagner L, Stephan M, von Horsten S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4’s (DPP4) entanglement in the immune system. Clin Exp Immunol 185, 1–21, 2016.10.1111/cei.12781Search in Google Scholar

Kooijman R, Coppens A, Hooghe-Peters EL. Insulin-like growth factor-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology 143, 1206–1212, 2002.10.1210/endo.143.4.8725Search in Google Scholar

Kooijman R, Coppens A, Hooghe-Peters E. IGF-1 stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase. Cell Signal 15, 1091–1098, 2003.10.1016/S0898-6568(03)00069-XSearch in Google Scholar

Kooijman R, Coppens A. Insulin-like growth facator-1 stimulates IL-10 production in human T cells. J Leukoc Biol 76, 862–867, 2004.10.1189/jlb.040424815277570Search in Google Scholar

Koval HD, Chopyak VV, Kamyshnyi OM, Kurpisz MK. Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Cent Eur J Immunol 43, 90–96, 2018.10.5114/ceji.2018.74878592717829736151Search in Google Scholar

Krynytska І, Marushchak M. The indices of nitric oxide system in rats with carrageenan-induced enterocolitis combined with diabetes mellitus. Rom J Diabetes Nutr Metab Dis 25, 283–288, 2018.10.2478/rjdnmd-2018-0033Search in Google Scholar

Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J. The soluble form of DPP4 is characterized as adipokine Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60, 1917–1925, 2011.10.2337/db10-1707Search in Google Scholar

Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 248, 67–76, 2000.10.1046/j.1365-2796.2000.00705.xSearch in Google Scholar

LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3, 302–310, 2007.10.1038/ncpendmet0427Search in Google Scholar

Liu TY, Uemura Y, Suzuki M, Narita Y, Hirata S, Ohyama H, Ishihara O, Matsushita S. Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. Eur J Immunol 38, 1012–1023, 2008.10.1002/eji.200737838Search in Google Scholar

Liu X, Linnington C, Webster HD, Lassmann S, Yao DL, Hudson LD, Wekerle H, Kreutzberg GW. Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis. J Neurosci Res 47, 531–538, 1997.10.1002/(SICI)1097-4547(19970301)47:5<531::AID-JNR8>3.0.CO;2-ISearch in Google Scholar

Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG, Rathmell JC. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186, 3299–3303, 2011.10.4049/jimmunol.1003613Search in Google Scholar

Nguyen-Chi M, Laplace-Builhe B, Travnickova J, Luz-Crawford P, Tejedor G, Lutfalla G, Kissa K, Jorgensen C, Djouad F. TNF signaling and macrophages govern fin regeneration in zebrafish larvae. Cell Death Dis 8, e2979, 2017.10.1038/cddis.2017.374Search in Google Scholar

Ogata H, Seino Y, Harada N, Iida A, Suzuki K, Izumoto T, Ishikawa K, Uenishi E, Ozaki N, Hayashi Y, Miki T, Inagaki N, Tsunekawa S, Hamada Y, Seino S, Oiso Y. KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state. J Endocrinol 222, 191–200, 2014.10.1530/JOE-14-0161Search in Google Scholar

Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 22, 314–320, 2010.10.1016/j.coi.2010.01.018Search in Google Scholar

Poppi L, Dixit VD, Baratta M, Giustina A, Tamanini C, Parvizi N. Growth hormone secretatogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes. Exp Clin Endocrinol Diabetes 110, 343–347, 2002.10.1055/s-2002-34991Search in Google Scholar

Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B, Ding ZM. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose co-transporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther 345, 250–259, 2013.10.1124/jpet.113.20336423487174Search in Google Scholar

Putilin DA, Kamyshnyi AM. Сhanges of glut1, mtor and ampk1α gene expression in pancreatic lymph node lymphocytes of rats with experimental diabetes mellitus. Medical Immunology (Russia) 18, 339–346, 2016.10.15789/1563-0625-2016-4-339-346Search in Google Scholar

Qiao YC, Shen J, He L, Hong XZ, Tian F, Pan YH, Liang L, Zhang XX, Zhao HL. Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes Res 2016, 3694957, 2016.10.1155/2016/3694957506198027777959Search in Google Scholar

Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, Zhao HL. The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PLoS One 12, e0176157, 2017.10.1371/journal.pone.0176157539863328426801Search in Google Scholar

Roder PV, Geillinger KE, Zietek TS, Thorens B, Koepsell H, Daniel H. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One 9, e89977, 2014.10.1371/journal.pone.0089977393595524587162Search in Google Scholar

Salgado FJ, Vela E, Martin M, Franco R, Nogueira M, Cordero OJ. Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine 12, 1136–1141, 2000.10.1006/cyto.1999.064310880264Search in Google Scholar

Sell H, Bluher M, Kloting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36, 4083–4090, 2013.10.2337/dc13-0496383615324130353Search in Google Scholar

Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208, 1367–1376, 2011.10.1084/jem.20110278313537021708926Search in Google Scholar

Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev 62, 199–236, 2010.10.1124/pr.109.002469287991320392809Search in Google Scholar

Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets 4, 493–503, 2003.10.2174/138945003349096612866664Search in Google Scholar

Topol IA, Kamyshny AM, Abramov AV, Kolesnik YM. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziolohichnyi zhurnal 60, 38–44, 2014.10.15407/fz60.02.038Search in Google Scholar

Tu W, Cheung PT, Lau YL. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J Immunol 165, 1331–1336, 2000.10.4049/jimmunol.165.3.133110903734Search in Google Scholar

Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302–316, 2019.10.1016/j.immuni.2019.01.02030784578Search in Google Scholar

Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev 91, 733–794, 2011.10.1152/physrev.00055.200921527736Search in Google Scholar

Wu J, Yan LJ. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Diabetes Metab Syndr Obes 8, 181–188, 2015.10.2147/DMSO.S82272439651725897251Search in Google Scholar

Wynes M, Riches D. Induction of macrophage insulin-like growth factor-1 expression by the Th2 cytokines IL-4 and IL-13. J Immunol 171, 3550–3559, 2003.10.4049/jimmunol.171.7.355014500651Search in Google Scholar

Yang K, Chi H. Metabolic control of Th17 cell generation and CNS inflammation. J Neurol Neurophysiol S12–004, 2014.10.4172/2155-9562.S12-004433438225705564Search in Google Scholar

Yazbeck R, Howarth GS, Abbott CA. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci 30, 600–607, 2009.10.1016/j.tips.2009.08.00319837468Search in Google Scholar

Yuan T, Zhao WG, Sun Q, Fu Y, Dong YY, Dong YX, Yang GH, Wang H. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population. Chin Med J (Engl) 123, 2018–2022, 2010.Search in Google Scholar

Zeng C, Shi X, Zhang B, Liu H, Zhang L, Ding W, Zhao Y. The imbalance of Th17/Th1/ Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 90, 175–186, 2012.10.1007/s00109-011-0816-521964948Search in Google Scholar

Zeng T, Zhang CL, Zhao XL, Xie KQ. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. Eur J Gastroenterol Hepatol 26, 646–653, 2014.10.1097/MEG.000000000000006824743504Search in Google Scholar

Zherebiatiev A, Kamyshnyi A. Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis. Iran J Allergy Asthma Immunol 15, 39–45, 2016.Search in Google Scholar

Zietek T, Daniel H. Intestinal nutrient sensing and blood glucose control. Curr Opin Clin Nutr Metab Care 18, 381–388, 2015.10.1097/MCO.000000000000018726001654Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo